As the novel coronavirus (COVID-19) has reached pandemic levels, companies of all sizes and in all industries face myriad impacts to business operations and the health and well-being of employees.
To help clients navigate these new challenges, including the unpredictability
Continue Reading KDW COVID-19 Resource Center Provides Critical Business Guidance
The push and pull on CBD regulation continues.
Earlier this week, Minnesota Representative Colin Peterson introduced a H.R. 5587, which would regulate CBD as a dietary supplement. Specifically, the bill would amend the federal Food, Drug, and Cosmetic Act
Continue Reading House Bill Introduced to Treat CBD as Dietary Supplement While FDA Grapples With Reporting Deadlines and Data Gaps
Cannabis is in the midst of a historic transformation from the black market to a regulated, lucrative, global industry. But investing in cannabis, or doing business with companies involved in cannabis production or distribution, comes with substantial legal and other
Continue Reading Navigating the Green Rush: Due Diligence Considerations for Cannabis Investments
On 24 September, European regulators cleared the way for GW Pharma’s cannabinoid medicinal product to treat patients with two rare, severe forms of epilepsy. The European Commission approved Epidyolex to treat seizures associated with Lennox Gastaut syndrome (LGS) or Dravet
Continue Reading Navigating the Haze of Cannabis Rules and Regulations in Europe
On August 19, 2019, the National Credit Union Administration (“NCUA”) made an economically significant change to the hemp banking landscape. As is the case with cannabis businesses generally, hemp operations have faced considerable limitations with respect to access to traditional
Continue Reading Credit Unions Lending to Hemp-Related Businesses is Permissible
On August 9, Governor Phil Murphy signed into law Assembly Bill 5322, establishing the state’s program for cultivation, handling, processing, transport, and sale of hemp. The bill also repeals the New Jersey Industrial Hemp Pilot Program, which was passed
Continue Reading New Jersey Gives Green Light to Industrial Hemp Program
We’ve written a lot about FDA’s current position on CBD in food and the ongoing process to evaluate a potential non-drug pathway for the ingredient that emerged seemingly out of nowhere to capture the attention of consumers, legislators, and regulators
Continue Reading NY and Ohio: Recent Legal Changes Diverge on Whether CBD Can Be Added to Food
On May 28, 2019, the United States Department of Agriculture’s (“USDA”) Office of the General Counsel issued a Legal Opinion, which attempts to address open questions relating to interstate transport of hemp. While the 2018 Farm Bill legalized hemp production,
Continue Reading USDA Legal Opinion Seeks To Clarify Interstate Transport of Hemp
FDA’s CBD Public Meeting featured a full house of manufacturers, researchers, health professionals, trade association representatives, and other stakeholders. Each speaker was given a few minutes to offer their input in response to FDA’s call for submissions relating to health
Continue Reading FDA CBD Public Meeting Features Overwhelming Calls For Robust Regulation and Enforcement; Relaxation of Obstacles to Research
The Alcohol and Tobacco Tax and Trade Bureau (“TTB”) recently updated its guidance on inclusion of hemp ingredients in beverages containing alcohol. Here’s a summary:
Continue Reading TTB Updates Guidance on Hemp Ingredients, Follows FDA’s Lead
